{"pub": "yahoo", "url": "https://finance.yahoo.com/news/week-cannabis-vape-craze-raises-153248924.html", "downloaded_at": "2019-09-08 23:29:34.330822+00:00", "title": "The Week In Cannabis: The Vape Craze, Raises Hit $10B, Aurora Cashes In On TGOD, Seth Rogen's Charity Goes Green", "language": "en", "text": "The vape craze took over the news this week, as the U.S. debated the perils of vaporized marijuana, following an outbreak of vaping-associated lung illnesses. On Thursday, the New York State Department of Health came out with a theory around vitamin E acetate being the culprit. Meanwhile, Washington, D.C. enacted a law that provides protections to government employees who consume medical marijuana.\n\nOn the markets front, we learned cannabis-related capital raises, deals and M&A transactions had almost hit $10 billion this year through the end of August. This number compares to roughly $5.5 billion raised over the same period of time last year. Cultivation and retail subsegments of the industry continued to attract the majority of investments, same as in previous years.\n\nWhile many were investing in the cannabis space, Aurora Cannabis Inc. (NYSE: ACB) has started cashing out on some of its investments. On Wednesday, the company said it had sold all of its remaining shares of The Green Organic Dutchman Holdings Ltd (OTC: TGODF) (TSE: TGOD). The stake, comprised of 28.83 million TGOD shares, accounted for 10.5% of the total number of outstanding shares. Sold at a price of $3.00 per share, Aurora received gross proceeds of $86.5 million. Even though Aurora doesn\u2019t own any TGOD shares any longer, it still owns warrants to purchase 16.67 million shares in the future.\n\nIf you want to get this news recap in your email inbox every week, please subscribe to https://tinyletter.com/javierhasse\n\nDebra Borchardt, CEO of Green Market Report, highlighted Aurora\u2019s 50% return on its TGOD investment.\n\n\u201cWhy sit on this money if you can use it, right?\u201d she asks. \u201cHowever, I worry that Aurora is going to need even more money as it waits for its numerous acquisitions to pay off.\u201d\n\nClick here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.\n\nCannabis ETFs delivered strong gains. Over the last five trading days:\n\n\u2022 The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) (TSE:HMMJ) rose 8.77%\n\n\u2022 The ETFMG Alternative Harvest ETF (NYSE: MJ) gained 7.1%\n\n\u2022 The AdvisorShares Pure Cannabis ETF (NYSE: YOLO) was up 7.23%\n\n\u2022 The Cannabis ETF (NYSE: THCX) spiked 8%\n\n\u2022 The Amplify Seymour Cannabis ETF (NYSE: CNBS) escalated 7.64%\n\n\u2022 The SPDR S&P 500 ETF Trust (NYSE: SPY) closed the period up 1.9%\n\nGains were especially stronger during the four days of this week, as the ETFs recuperated from a slow Friday last week.\n\nMore News From The Week\n\nWe learned the next Hilarity for Charity event, hosted by actor Seth Rogen, will feature \u201ccomedians running game booths and marijuana aplenty,\u201d all in the benefit of an Alzheimer\u2019s charity.\n\nAdam Devine, Ben Feldman, Andrew Rannells, Ilana Glazer, Casey Wilson, Kate Micucci, Nick Kroll, Regina Hall, Ike Barinholtz, Jeff Ross, Riki Lindhome, Tony Hawk and Anderson .Paak have reportedly signed on for the event already.\n\nSOL Global Investments Corp (OTC: SOLCF) announced Andrew DeFrancesco will step down as the company's chairman. He will helm a new investment company, SOL Investment Group, which will acquire SOL Global's assets as the company transitions to Bluma Wellness and HeavenlyRx. SOL Global's CEO Brady Cobb will oversee Bluma Wellness, while former Kellogg's President Paul Norman will lead HeavenlyRx. Further details of the shift will be provided over the next month,\n\n\u201cI fortunately surrounded myself with an amazing team led by Brady Cobb with Peter Liabotis and Brad Morris, who are constantly pushing seven days a week to exceed our goals,\u201d DeFrancesco told Benzinga.\n\nMedicine Man Technologies, Inc. (OTC: MDCL) signed a binding term sheet to purchase five Starbuds dispensaries in Colorado. The company also announced it has signed a binding term sheet to purchase four additional Colorado dispensaries, owned by Colorado Harvest Company.\n\nMarket research and data analytics firm Prohibition Partners has released its first North American Cannabis Report. In the 134-page paper, the firm analyzes the current state of the cannabis industry in Canada and the United States to draw key insights into the industry\u2019s future in the region.\n\nThe firm is estimating that by 2024, the continent's cannabis market will be worth $47.3 billion.\n\nWe learned Nevada cannabis dispensaries, cultivators, laboratories and producers have paid more than $109 million in excise taxes and fees over the course of fiscal year 2019, breaking the $100 million mark for the first time. Taxes alone amounted to $99.18 million, up from $74.7 million last year.\n\nStory continues", "description": "On Thursday, the New York State Department of Health came out with a theory around vitamin E acetate being the culprit.  Meanwhile, Washington, D.C. enacted a law that provides protections to government employees who consume medical marijuana.  While many were investing in the cannabis space, Aurora", "authors": ["Javier Hasse"], "top_image": "https://s.yimg.com/os/mit/media/p/common/images/favicon_new-7483e38.svg", "published_at": "2019-09-08"}